» Authors » Boris Chaumette

Boris Chaumette

Explore the profile of Boris Chaumette including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 72
Citations 1605
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Perry J, Bunnik E, Rietschel M, Bentzen H, Ingvoldstad Malmgren C, Pawlak J, et al.
Psychiatr Genet . 2025 Feb; 35(2):26-36. PMID: 39945108
Objective: This position article discusses current major ethical and social issues related to genetic counseling and testing in clinical psychiatry (PsyGCT). Methods: To address these complex issues in the context...
2.
Sandroni V, Chaumette B
Genes Brain Behav . 2025 Jan; 24(1):e70013. PMID: 39801370
Schizophrenia is a frequent and disabling disease. The persistence of the disorder despite its harmful consequences represents an evolutionary paradox. Based on recent discoveries in genetics, scientists have formulated the...
3.
Verstuyft C, Dewolf D, Blin O, Florentin V, Mesnard L, Chaumette B, et al.
Therapie . 2025 Jan; 80(1):103-112. PMID: 39788802
4P medicine (personalized, preventive, predictive, and participatory) is experiencing a remarkable rise, and pharmacogenetics is an essential part of it. However, several obstacles are hindering its deployment. This round table...
4.
Iftimovici A, Martinez G, Victor J, Bendjemaa N, Jantac C, Danset-Alexandre C, et al.
Schizophr Bull . 2025 Jan; PMID: 39756426
Background And Hypothesis: While age at onset in schizophrenia (SCZ) is usually defined by age at onset of psychosis, the illness actually occurs earlier, with a prodrome often starting in...
5.
Cerulli Irelli E, Fanella M, Chaumette B, Putotto C, Mignot C, Mazzeo A, et al.
Epilepsia . 2024 Dec; 66(3):859-869. PMID: 39718534
Objective: This study was undertaken to characterize the clinical and genetic features of patients with 22q11.2 deletion syndrome (22q11.2DS) and generalized epilepsy compared with 22q11.2DS individuals without epilepsy. Methods: This...
6.
Verstuyft C, Dewolf D, Blin O, Florentin V, Mesnard L, Chaumette B, et al.
Therapie . 2024 Dec; 80(1):93-102. PMID: 39710540
No abstract available.
7.
Yeh D, He Q, Krebs E, Iftimovici A, Martinez G, Bourgin-Duchesnay J, et al.
Psychol Med . 2024 Dec; :1-12. PMID: 39620480
Background: Cognitive impairment constitutes a prevailing issue in the schizophrenia spectrum, severely impacting patients' functional outcomes. A global cognitive score, sensitive to the stages of the spectrum, would benefit the...
8.
Leblond C, Rolland T, Barthome E, Mougin Z, Fleury M, Ecker C, et al.
Annu Rev Genet . 2024 Nov; 58(1):487-512. PMID: 39585908
Autism represents a large spectrum of diverse individuals with varying underlying genetic architectures and needs. For some individuals, a single de novo or ultrarare genetic variant has a large effect...
9.
Mathan J, Maximino-Pinheiro M, He Q, Rezende G, Menu I, Tissier C, et al.
Cereb Cortex . 2024 Nov; 34(11). PMID: 39526525
Emerging evidence underscores the prenatal period's critical role in shaping later cognition and health, influenced by an intricate interplay of parental genetic and environmental factors. Birth weight is commonly used...
10.
Guardiola-Ripoll M, Sotero-Moreno A, Chaumette B, Kebir O, Hostalet N, Almodovar-Paya C, et al.
Biomedicines . 2024 Oct; 12(10). PMID: 39457583
Dermatoglyphic pattern deviances have been associated with schizophrenia-spectrum disorders (SSD) and are considered neurodevelopment vulnerability markers based on the shared ectodermal origin of the epidermis and the central nervous system....